Search results
Adcentrx Therapeutics Announces China NMPA Grants IND Clearance for ADRX-0706, a Novel Nectin-4 ADC...
FOX 4 Kansas City· 6 hours ago...accelerate patient enrollment into the Phase 1a/1b studySAN DIEGO and SHANGHAI, May 6, 2024 /PRNewswire/ -- Adcentrx Therapeutics ("Adcentrx"), a biotechnology company revolutionizing Antibody-Drug Conjugate (ADC) therapeutics for cancer and other life-threatening diseases, announced today that...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 7 days agoA Potential First-In-Class Drug: CDE Approved Single-Arm Pivotal Clinical Study of LBL-024, An Anti-PD-L1/4-1BB Bispecific Antibody Developed by Leads Biolabs PR Newswire ...
ProMIS Neurosciences Publishes Study Highlighting Oligomer Selectivity and Benefit of...
Digital Journal· 7 days agoProMIS Neurosciences Inc. (Nasdaq: PMN), a biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative ...
Spyre Therapeutics Announces Grants of Inducement Awards
WKRN Nashville· 3 days agoSpyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a development-stage biotechnology company advancing best-in-class antibody engineering, rational therapeutic ...
...IND) Application for EB-105 - A Novel Trispecific Fusion Antibody for Diabetic Macular Edema...
WTNH-TV New Haven· 7 days agoEB-105 is a novel trispecific fusion antibody targeting VEGF-A (and isomers), VEGF-B, placental...
Vagus nerve activation of the spleen shows promise to treat infections
Medical Xpress· 14 hours agoNew research published in Science Advances by the Feinstein Institutes for Medical Research scientists shows that activation of the vagus nerve triggers the spleen, thereby regulating the production ...
AbCellera Biologics Q1 2024 Earnings Preview
Seeking Alpha· 8 hours agoAbCellera Biologics is set to announce its Q1 earnings results, with a consensus EPS estimate of -$0.16 and a revenue estimate of $10.85M.
Patients with rheumatoid arthritis have unique and complex autoantibody patterns, study reveals
Medical Xpress· 6 days agoRheumatoid arthritis is a chronic autoimmune disease that primarily affects the joints, causing...
Tackling a Pathogen That Leaves a Lasting Impression
The Scientist· 1 day agoStaphylococcus aureus (S. aureus) has a complicated relationship with humans. While this commensal bacterium colonizes approximately 20-30 percent of...
Drug appears to reverse type 1 diabetes in mice
Futurity· 7 days agoAn experimental monoclonal antibody drug appears to prevent and reverse the onset of clinical type 1 diabetes in mice, and in some cases, to lengthen the animals’ lifespan ...